Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CYSLTR1 Rabbit anti-Human, Polyclonal Antibody, Abnova™

Rabbit polyclonal antibody raised against synthetic peptide of CYSLTR1.

Supplier:  Abnova Corporation PAB25008

Catalog No. 89-126-685


Only null left
Add to Cart

Description

Description

The cysteinyl leukotrienes LTC4, LTD4, and LTE4 are important mediators of human bronchial asthma. Pharmacologic studies have determined that cysteinyl leukotrienes activate at least 2 receptors, the protein encoded by this gene and CYSLTR2. This encoded receptor is a member of the superfamily of G protein-coupled receptors. Activation of this receptor by LTD4 results in contraction and proliferation of smooth muscle, oedema, eosinophil migration and damage to the mucus layer in the lung. [provided by RefSeq

Specifications

Specifications

CYSLTR1
Polyclonal
Unconjugated
Western Blot (1:500-1:1000) Immunofluorescence (1:50-1:200) The optimal working dilution should be determined by the end user.
CYSLTR1
CYSLTR1
A synthetic peptide corresponding to CYSLTR1.
100 μL
Primary
CYSLTR1 polyclonal antibody detects endogenous levels of CYSLTR1.
Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.
Immunofluorescence, Western Blot
1 mg/mL
Rabbit polyclonal antibody raised against synthetic peptide of CYSLTR1.
In PBS, pH 7.2 (0.05% sodium azide)
CYSLT1/CYSLT1R/CYSLTR/HG55/HMTMF81/MGC46139
Rabbit
Antigen affinity purification
RUO
10800
Human
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.

For Research Use Only